SG11202004692UA - Pyrazolopyrimidines having activity against the respiratory syncytial virus (rsv) - Google Patents
Pyrazolopyrimidines having activity against the respiratory syncytial virus (rsv)Info
- Publication number
- SG11202004692UA SG11202004692UA SG11202004692UA SG11202004692UA SG11202004692UA SG 11202004692U A SG11202004692U A SG 11202004692UA SG 11202004692U A SG11202004692U A SG 11202004692UA SG 11202004692U A SG11202004692U A SG 11202004692UA SG 11202004692U A SG11202004692U A SG 11202004692UA
- Authority
- SG
- Singapore
- Prior art keywords
- pyrazolopyrimidines
- rsv
- activity against
- respiratory syncytial
- syncytial virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17204280 | 2017-11-29 | ||
| PCT/EP2018/082828 WO2019106004A1 (en) | 2017-11-29 | 2018-11-28 | Pyrazolopyrimidines having activity against the respiratory syncytial virus (rsv) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202004692UA true SG11202004692UA (en) | 2020-06-29 |
Family
ID=60582408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202004692UA SG11202004692UA (en) | 2017-11-29 | 2018-11-28 | Pyrazolopyrimidines having activity against the respiratory syncytial virus (rsv) |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11339165B2 (ru) |
| EP (1) | EP3717486B1 (ru) |
| JP (1) | JP7273814B2 (ru) |
| KR (1) | KR20200094136A (ru) |
| CN (1) | CN111417635B (ru) |
| AR (1) | AR113853A1 (ru) |
| AU (1) | AU2018377993B2 (ru) |
| BR (1) | BR112020009507A2 (ru) |
| CA (1) | CA3079126A1 (ru) |
| CL (1) | CL2020001353A1 (ru) |
| EA (1) | EA202091341A1 (ru) |
| ES (1) | ES2918186T3 (ru) |
| IL (1) | IL274898A (ru) |
| MA (1) | MA51197A (ru) |
| MX (1) | MX2020005570A (ru) |
| PH (1) | PH12020550673A1 (ru) |
| SG (1) | SG11202004692UA (ru) |
| TW (1) | TW201932470A (ru) |
| WO (1) | WO2019106004A1 (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200116099A (ko) * | 2018-01-31 | 2020-10-08 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | Rsv에 대한 활성을 갖는 시클로알킬 치환 피라졸로피리미딘 |
| MA52348A (fr) | 2018-04-23 | 2021-03-03 | Janssen Sciences Ireland Unlimited Co | Composés hétéroaromatiques ayant une activité contre vrs |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0802916A1 (en) | 1994-12-22 | 1997-10-29 | Biochem Pharma Inc | Low molecular weight bicyclic thrombin inhibitors |
| CA2225255A1 (en) | 1995-06-29 | 1997-01-16 | Merck & Co., Inc. | Combinations of inhibitors of farnesyl-protein transferase |
| ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
| US5977134A (en) | 1996-12-05 | 1999-11-02 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5972966A (en) | 1996-12-05 | 1999-10-26 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US6177443B1 (en) | 1997-03-07 | 2001-01-23 | Novo Nordisk A/S | 4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use |
| CN1361766A (zh) | 1999-07-19 | 2002-07-31 | 盐野义制药株式会社 | 具有酰氧基甲氧基羰基侧链的三环化合物 |
| EP1113007A1 (en) | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| AU2002332659A1 (en) | 2001-08-21 | 2003-03-03 | Sepracor, Inc. | 2-substituted piperidines that are ligands for monoamine receptors and transporters |
| MXPA04010441A (es) | 2002-04-23 | 2005-02-14 | Shionogi & Co | Derivado de pirazolo[1,5-a]pirimidina e inhibidor de nad(p)h oxidasa que contiene el mismo. |
| AU2002357644A1 (en) | 2002-09-20 | 2004-04-08 | Medisyn Technologies, Inc. | Therapeutic agents and corresponding treatments |
| MXPA05003195A (es) | 2002-09-26 | 2005-06-08 | Pfizer | Derivados de pirazol como inhibidores de la transcriptasa inversa. |
| WO2004037817A1 (ja) | 2002-10-25 | 2004-05-06 | Mitsubishi Pharma Corporation | Ｎ−オキシド化合物 |
| TW200505902A (en) | 2003-03-20 | 2005-02-16 | Schering Corp | Cannabinoid receptor ligands |
| EP2258365B1 (en) | 2003-03-28 | 2013-05-29 | Novartis Vaccines and Diagnostics, Inc. | Use of organic compounds for immunopotentiation |
| FR2856596B1 (fr) | 2003-06-27 | 2007-04-27 | Bioprojet Soc Civ | Nouvelle association medicamenteuse psychiatrique et utilisation d'une antagoniste ou agoniste inverse du recepteur h3 de l'histamine pour preparer un medicament prevenant des effets indesirables de psychotropes. |
| WO2005035516A1 (ja) | 2003-10-10 | 2005-04-21 | Ono Pharmaceutical Co., Ltd. | 新規縮合複素環化合物およびその用途 |
| CA2541618C (en) | 2003-10-30 | 2011-12-13 | Boehringer Ingelheim (Canada) Ltd. | Rsv polymerase inhibitors |
| AR046959A1 (es) | 2003-12-18 | 2006-01-04 | Tibotec Pharm Ltd | Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio |
| DE602004031258D1 (de) | 2003-12-24 | 2011-03-10 | Biota Scient Management | Polycyclische mittel zur behandlung von infektione |
| KR101231466B1 (ko) | 2004-09-13 | 2013-02-07 | 오노 야꾸힝 고교 가부시키가이샤 | 질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는약제 |
| WO2006034341A2 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| WO2007044085A2 (en) | 2005-05-19 | 2007-04-19 | Xenon Pharmaceuticals Inc. | Heteroaryl compounds and their uses as therapeutic agents |
| RU2434000C2 (ru) | 2005-06-20 | 2011-11-20 | Тиботек Фармасьютикалз Лтд. | 1-(2-амино-3-(замещенный алкил)-3н-бензимидазоилметил)-3-замещенные-1,3-дигидробензоимидазол-2-оны с активностью в отношении респираторно-синцитиального вируса |
| US7507842B2 (en) | 2005-08-12 | 2009-03-24 | Radiorx, Inc. | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof |
| WO2007060409A1 (en) | 2005-11-23 | 2007-05-31 | Astrazeneca Ab | L-alanine derivatives |
| EP2102211A2 (en) | 2006-11-20 | 2009-09-23 | Alantos Pharmaceuticals Holding, Inc. | Heterobicyclic metalloprotease inhibitors |
| JP2010535773A (ja) | 2007-08-10 | 2010-11-25 | グラクソスミスクライン エルエルシー | ウイルス感染を治療するための窒素含有二環式化学物質 |
| EP2229381A1 (en) | 2007-12-06 | 2010-09-22 | Schering Corporation | Gamma secretase modulators |
| MX2011002263A (es) | 2008-09-10 | 2011-05-23 | Kalypsys Inc | Aminopirimidinas como inhibidores de receptores de histamina para el tratamiento de enfermedades. |
| TW201022266A (en) | 2008-10-23 | 2010-06-16 | Boehringer Ingelheim Int | Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use |
| US20100204265A1 (en) | 2009-02-09 | 2010-08-12 | Genelabs Technologies, Inc. | Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections |
| KR20100101054A (ko) | 2009-03-07 | 2010-09-16 | 주식회사 메디젠텍 | 세포핵에서 세포질로의 ｇｓｋ３의 이동을 억제하는 화합물을 함유하는 세포핵에서 세포질로의 ｇｓｋ３ 이동에 의해 발생되는 질환의 치료 또는 예방용 약학적 조성물 |
| US9238647B2 (en) | 2009-03-23 | 2016-01-19 | Merck Sharp & Dohme Corp. | P2X3 receptor antagonists for treatment of pain |
| SG171708A1 (en) | 2009-06-11 | 2011-07-28 | Abbott Lab | Anti-viral compounds to treat hcv infection |
| US8937150B2 (en) | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
| EP3012258B1 (en) | 2010-06-24 | 2018-09-19 | Gilead Sciences, Inc. | Pharmaceutical composition comprising a pyrazolo[1,5-a]pyrimidine derivative as an antiviral agent |
| JP2015516976A (ja) | 2012-04-17 | 2015-06-18 | ギリアード サイエンシーズ， インコーポレイテッド | 抗ウイルス処置のための化合物および方法 |
| WO2015042297A1 (en) | 2013-09-20 | 2015-03-26 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Compounds for treating prostate can cancer |
| CA2935944A1 (en) | 2014-01-09 | 2015-07-16 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone | Substituted benzoxazine and related compounds |
| KR101551313B1 (ko) | 2014-07-28 | 2015-09-09 | 충남대학교산학협력단 | 신규한 인덴 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 망막 질환의 예방 또는 치료용 약학적 조성물 |
| CN107108556B (zh) | 2014-11-03 | 2020-09-29 | 艾欧米制药有限公司 | 药用化合物 |
| KR102522832B1 (ko) | 2014-12-08 | 2023-04-17 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 호흡기 세포융합 바이러스 （ｒｓｖ）의 복제에 대하여 저해 활성을 갖는 피페리딘 치환된 피라졸로［１，５―ａ］피리미딘 유도체 |
| CN105777632A (zh) | 2015-01-09 | 2016-07-20 | 成都贝斯凯瑞生物科技有限公司 | 芳环并氮杂环衍生物及其应用 |
| JO3637B1 (ar) | 2015-04-28 | 2020-08-27 | Janssen Sciences Ireland Uc | مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv |
-
2018
- 2018-11-27 TW TW107142176A patent/TW201932470A/zh unknown
- 2018-11-28 MA MA051197A patent/MA51197A/fr unknown
- 2018-11-28 JP JP2020529417A patent/JP7273814B2/ja active Active
- 2018-11-28 CN CN201880077163.6A patent/CN111417635B/zh active Active
- 2018-11-28 EP EP18807356.3A patent/EP3717486B1/en active Active
- 2018-11-28 WO PCT/EP2018/082828 patent/WO2019106004A1/en unknown
- 2018-11-28 CA CA3079126A patent/CA3079126A1/en active Pending
- 2018-11-28 KR KR1020207013976A patent/KR20200094136A/ko not_active Application Discontinuation
- 2018-11-28 MX MX2020005570A patent/MX2020005570A/es unknown
- 2018-11-28 EA EA202091341A patent/EA202091341A1/ru unknown
- 2018-11-28 AU AU2018377993A patent/AU2018377993B2/en active Active
- 2018-11-28 SG SG11202004692UA patent/SG11202004692UA/en unknown
- 2018-11-28 AR ARP180103493A patent/AR113853A1/es unknown
- 2018-11-28 ES ES18807356T patent/ES2918186T3/es active Active
- 2018-11-28 BR BR112020009507-9A patent/BR112020009507A2/pt unknown
- 2018-11-28 US US16/768,049 patent/US11339165B2/en active Active
-
2020
- 2020-05-21 PH PH12020550673A patent/PH12020550673A1/en unknown
- 2020-05-22 CL CL2020001353A patent/CL2020001353A1/es unknown
- 2020-05-25 IL IL274898A patent/IL274898A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US11339165B2 (en) | 2022-05-24 |
| PH12020550673A1 (en) | 2021-07-26 |
| CA3079126A1 (en) | 2019-06-06 |
| EP3717486B1 (en) | 2022-03-23 |
| MX2020005570A (es) | 2020-09-14 |
| EP3717486A1 (en) | 2020-10-07 |
| CL2020001353A1 (es) | 2020-09-25 |
| JP7273814B2 (ja) | 2023-05-15 |
| JP2021504408A (ja) | 2021-02-15 |
| AU2018377993A1 (en) | 2020-04-23 |
| AR113853A1 (es) | 2020-06-17 |
| WO2019106004A1 (en) | 2019-06-06 |
| BR112020009507A2 (pt) | 2020-11-03 |
| MA51197A (fr) | 2020-10-07 |
| CN111417635A (zh) | 2020-07-14 |
| KR20200094136A (ko) | 2020-08-06 |
| TW201932470A (zh) | 2019-08-16 |
| AU2018377993B2 (en) | 2023-01-12 |
| IL274898A (en) | 2020-07-30 |
| ES2918186T3 (es) | 2022-07-14 |
| EA202091341A1 (ru) | 2020-08-26 |
| CN111417635B (zh) | 2024-01-02 |
| US20200361942A1 (en) | 2020-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3595713A4 (en) | RESPIRATORY SYNCYTIAL VIRUS VACCINE | |
| HK1254950A1 (zh) | 中和人體呼吸道合胞體病毒的抗體 | |
| HK1249069A1 (zh) | 呼吸面罩、系統和方法 | |
| EP3645098A4 (en) | RESPIRATORY MASK SYSTEM | |
| EP3429670A4 (en) | RESPIRATOR SYSTEM | |
| EP3365008A4 (en) | VACCINE AGAINST RESPIRATORY SYNZYTIAL VIRUS | |
| ZA201703899B (en) | Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv) | |
| EP3385278A4 (en) | Full human antibody against respiratory syncytial virus | |
| EP3727544A4 (en) | RESPIRATORY MASK SYSTEM | |
| HK1258545A1 (zh) | 一種脲類化合物、其製備方法及其醫藥用途 | |
| EP3535008A4 (en) | RESPIRATORY THERAPY SYSTEMS IN A SECURE NETWORK | |
| PT3438095T (pt) | Composto de piridazinona ou seu sal, e herbicida que o contém | |
| SG11201908281VA (en) | Phenalene-1-one-containing photosensitizer composition, phenalene-1-one compound and the use thereof | |
| EP3731837A4 (en) | COMBINATION CONTAINING LINAGLIPTIN AND METFORMIN | |
| PT3369451T (pt) | Máscara respiratória sem armação | |
| ZA201800940B (en) | Use of il-3, il-33, and il-12p40 for characterization of the respiratory infections by syncytial respiratory virus | |
| EP3328859A4 (en) | INHIBITORS OF SYNCYTIAL RESPIRATORY VIRUS | |
| IL274898A (en) | Pyrazolopyrimidines with activity against respiratory syncytial virus | |
| IL243952A0 (en) | The aerial spraying assembly, and systems and methods for aerial spraying | |
| EP3775174A4 (en) | RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINES | |
| HUE047054T2 (hu) | Javított tömítésû maszk légzésterápiához | |
| GB201717918D0 (en) | Spray configuration | |
| EP3449976A4 (en) | BREATH GATING SYSTEM | |
| ZA202003139B (en) | Active breathing system | |
| EP3369430A4 (en) | THERAPEUTIC AGENT AGAINST ACUTE RESPIRATORY SYNDROME |